Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
157.2 USD | +2.33% | +20.27% | -12.69% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Other languages